{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Watt SA"],"funding":["Cancer Research UK"],"pagination":["4666-77"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3219832"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["30(46)"],"pubmed_abstract":["Identifying therapeutic targets for cancer treatment relies on consistent changes within particular types or sub-types of malignancy. The ability to define either consistent changes or sub-types of malignancy is often masked by tumor heterogeneity. To elucidate therapeutic targets in cutaneous squamous cell carcinoma (cSCC), the most frequent skin neoplasm with malignant potential, we have developed an integrated approach to gene expression profiling beginning with primary keratinocytes in culture. Candidate drivers of cSCC development were derived by first defining a set of in vitro cancer genes and then comparing their expression in a range of clinical data sets containing normal skin, cSCC and the benign hyper-proliferative condition psoriasis. A small interfering RNA (siRNA) screen of "],"journal":["Oncogene"],"pubmed_title":["Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma."],"pmcid":["PMC3219832"],"funding_grant_id":["A7874","13044"],"pubmed_authors":["Evans A","McGrath JA","Foerster J","Pratt N","Mein C","Leigh IM","Bruckner-Tuderman L","Thompson AM","Proby CM","South AP","Pourreyron C","Purdie K","Cole CL","Foster N","Hogan C","Appleyard V","Watt SA","Mao X","Murray K","Bourdon JC"],"additional_accession":[]},"is_claimable":false,"name":"Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma.","description":"Identifying therapeutic targets for cancer treatment relies on consistent changes within particular types or sub-types of malignancy. The ability to define either consistent changes or sub-types of malignancy is often masked by tumor heterogeneity. To elucidate therapeutic targets in cutaneous squamous cell carcinoma (cSCC), the most frequent skin neoplasm with malignant potential, we have developed an integrated approach to gene expression profiling beginning with primary keratinocytes in culture. Candidate drivers of cSCC development were derived by first defining a set of in vitro cancer genes and then comparing their expression in a range of clinical data sets containing normal skin, cSCC and the benign hyper-proliferative condition psoriasis. A small interfering RNA (siRNA) screen of ","dates":{"release":"2011-01-01T00:00:00Z","publication":"2011 Nov","modification":"2025-04-04T21:13:42.163Z","creation":"2019-03-27T00:46:10Z"},"accession":"S-EPMC3219832","cross_references":{"pubmed":["21602893"],"doi":["10.1038/onc.2011.180"]}}